Kiora Pharmaceuticals Stock (NASDAQ: KPRX) stock price, news, charts, stock research, profile.
Open | $0.491 |
Close | $0.480 |
Volume / Avg. | 50.485K / 1.659M |
Day Range | 0.475 - 0.494 |
52 Wk Range | 0.451 - 5.250 |
Market Cap | $12.729M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 0.19% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Kiora Pharmaceuticals (NASDAQ: KPRX) through any online brokerage.
Other companies in Kiora Pharmaceuticals’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Universe Pharmaceuticals (NASDAQ:UPC) and Palisade Bio (NASDAQ:PALI).
The latest price target for Kiora Pharmaceuticals (NASDAQ: KPRX) was reported by HC Wainwright & Co. on Wednesday, March 27, 2024. The analyst firm set a price target for 2.00 expecting KPRX to rise to within 12 months (a possible 312.54% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Kiora Pharmaceuticals (NASDAQ: KPRX) is $0.4848 last updated April 25, 2024 at 6:24 PM EDT.
There are no upcoming dividends for Kiora Pharmaceuticals.
Kiora Pharmaceuticals’s Q4 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Kiora Pharmaceuticals.
Kiora Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.